Medical Publication

  • Home
  • Medical Publication

Medical Publication

  1. THERAPEUTIC POTENTIAL OF GLUTATHIONE AUGMENTATION IN CANCER PATIENTS RECEIVING CHEMOTHERAPY OR RADIOTHERAPY.
    Journal of Nutritional Oncology, March 9, 2017, Volume 1, Number 1.
    Jimmy Gutman.
  2. EFFECT OF CYSTEINE-RICH WHEY PROTEIN (IMMUNOCAL®) SUPPLEMENTATION IN COMBINATION WITH RESISTANCE TRAINING ON MUSCLE STRENGTH AND LEAN BODY MASS IN NON-FRAIL ELDERLY SUBJECTS: A RANDOMIZED, DOUBLE-BLIND CONTROLLED STUDY.
    The Journal of Nutrition, Health & Aging©, October 2014.
    A.D. Karelis, V. Messier, C. Suppere, P. Briand, R. Rabasa-Lhoret.
  3. PSORIASIS IMPROVEMENT IN PATIENTS USING GLUTATHIONE-ENHANCING, NONDENATURED WHEY PROTEIN ISOLATE – A Pilot Study.
    The Journal of Clinical and Aesthetic Dermatology, October 2013, Volume 6,Number 101.
    Ronald Prusick, Lisa Prisick, Jimmy Gutman.
  4. HEPATOLOGY – OPEN-LABELED PILOT STUDY OF CYSTEINE-RICH WHEY PROTEIN ISOLATE SUPPLEMENTATION FOR NONALCOHOLIC STEATOHEPATITIS PATIENTS.
    Journal of Gastroenterology and Hepatology 24(2009) 1045-1050.
    Taned Chitapanarux, Prasong Tienboon, Suwalee Pojchamarnwiputh and Donrawee Leelarungrayub.
  5. ORAL TOLERABILITY OF CYSTEINE-RICH WHEY PROTEIN ISOLATE IN AUTISM – A PILOT STUDY.
    JANA Vol. 11, No. 1, 2008.
    Janet K. Kern, Bruce D. Grannemann, Jimmy Gutman, Madhukar.H.
  6. CYSTEINE-RICH PROTEIN REVERSES WEIGHT LOSS IN LUNG CANCER PATIENTS RECEIVING CHEMOTHERAPY OR RADIOTHERAPY.
    Antioxidants & Redox Signaling Vol. 10, No. 2, 2008.
    Richard G. Tozer, Patricia Tal, Wilma Falconer, Thierry Ducruet, Annie Karabadjian, Gustavo Bounous, John H. Molson and Wulf Droge.
  7. CHILDREN’S ONCOLOGY GROUP (COG) NUTRITION COMMITTEE – EVALUATION OF A NEUTRACEUTICAL CYSTEINE DELIVERY AGENT IN THE MANAGEMENT OF WASTING IN HIGH-RISK CHILDHOOD CANCER PATIENTS.
    Pediatr Blood Cancer 2008; 50:447-450.
    Paul C. Rogers, Steven J. Melnick, Elena J. Ladas, Jacqueline Halton, Jacques Baillargeon, and Nancy Sacks.
  8. EFFECTS OF CYSTEINE DONOR SUPPLEMENTATION ON EXERCISE-INDUCED BRONCHOCONSTRICTION.
    Med Sci Sports Exerc.Vol. 37, No. 9, pp. 1468-1473, 2005.
    JM Baumann, KW Rundell, TM Evans, AM Levine.
  9. OXIDATIVE STRESS AND AGEING: IS AGEING A CYSTEINE DEFICIENCY SYNDROME?
    Phil. Trans. R. Soc. B. 360, 2355-2372 (2005).
    Droge W.
  10. MOLECULAR PATHOGENESIS AND PREVENTION OF PROSTATE CANCER.
    Anticancer Research 24: 553-554 (2004).
    Bounous G, Beer D.
  11. IMPROVED GLUTATHIONE STATUS IN YOUNG ADULT PATIENTS WITH CYSTIC FIBROSIS SUPPLEMENTED WITH WHEY PROTEIN.
    Journal of Cystic Fibrosis, Vol. 2, Issue 4, December 2003.
    V Grey, SR Mohammed, AA Smountas, R Bahlool, LC Lands.
  12. MILK WHEY PROTEIN DECREASES OXYGEN FREE RADICAL PRODUCTION IN A MURINE MODEL OF CHRONIC IRON-OVERLOAD CARDIOMYOPATHY.
    Can. J. Cardiol. Vol. 19, No. 10, September 2003.
    WJ Bartfay, MT Davies, JM Medves, S Lugowski.
  13. THE ANTIOXIDANT SYSTEM.
    Anticancer Research 23: 1411-1416 (2003).
    Bounous G, Molson JH.
  14. WHEY PROTEIN CONCENTRATE (WPC) AND GLUTATHIONE MODULATION IN CANCER TREATMENT.
    Anticancer Research 20: 4785-4792 (2000).
    Bounous G.
  15. TREATMENT OF OBSTRUCTIVE AIRWAY DISEASE WITH A CYSTEINE DONOR PROTEIN SUPPLEMENT: A CASE REPORT.
    Chest. 2000 Mar; 117(3): 914-6.
    Lothian B, Grey V, Kimoff RJ, Lands LC.
  16. NUTRITIONAL THERAPY OF CHRONIC HEPATITIS BY WHEY PROTEIN (NON-HEATED).
    Journal Of Medicine Vol. 31, Nos. 5&6, 2000.
    Watanabe A, Higuchi K, Okada K, Shimizu Y, Kondo Y, Kohri H.
  17. ENHANCING EFFECT OF PATENTED WHEY PROTEIN ISOLATE (IMMUNOCAL®) ON CYTOTOXICITY OF AN ANTICANCER DRUG.
    Nutrition and Cancer, 38(2), 200-208 (2000).
    Tsai WY, Chang WH, Chen CH, Lu FJ.
  18. THE EFFECT OF SUPPLEMENTATION WITH A CYSTEINE DONOR ON MUSCULAR PERFORMANCE.Journal of Applied Physiology 1999 Oct; 87(4): 1381-5.
    Lands LC, Grey VL, Smountas AA.
  19. COMPETITION FOR GLUTATHIONE PRECURSORS BETWEEN THE IMMUNE SYSTEM AND THE SKELETAL MUSCLE: PATHOGENESIS OF CHRONIC FATIGUE SYNDROME.
    Med Hypotheses 1999 Oct; 53(4) : 347-9.
    Bounous G, Molson J.
  20. NUTRICEUTICAL MODULATION OF GLUTATHIONE WITH A HUMANIZED NATIVE MILK SERUM PROTEIN ISOLATE, IMMUNOCAL®: APPLICATION IN AIDS AND CANCER. OXIDATIVE STRESS IN CANCER, AIDS, AND NEURODEGENERATIVE DISEASES.
    C.Pasquier et al. (eds) 1998; 447-461.
    Baruchel S, Viau G, Olivier R, Bounous G, Wainberg MA.
  21. IN VITRO SELECTIVE MODULATION OF CELLULAR GLUTATHIONE BY A HUMANIZED NATIVE MILK PROTEIN ISOLATE IN NORMAL CELLS AND RAT MAMMARY CARCINOMA MODEL.
    Anticancer Research 16: 1095-1100 (1996).
    Baruchel S, Viau G.
  22. THE USE OF A WHEY PROTEIN CONCENTRATE IN THE TREATMENT OF PATIENTS WITH METASTATIC CARCINOMA: A PHASE I-II CLINICAL STUDY.
    Anticancer Res. 1995 Nov-Dec; 15(6B): 2643-9.
    Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD.
  23. PLACE FOR AN ANTIOXIDANT THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION. OXIDATIVE STRESS, CELL ACTIVATION AND VIRAL INFECTION.
    C. Pasquier et al. (eds) 1994; 311-321.
    Baruchel S, Bounous G, Gold P.
  24. WHEY PROTEINS AS A FOOD SUPPLEMENT IN HIV-SEROPOSITIVE INDIVIDUALS.Clin Invest Med. 1993 Jun; 16(3): 204-9.
    Bounous G, Baruchel S, Falutz J, Gold P.
  25. THE BIOLOGICAL ACTIVITY OF UNDENATURED DIETARY WHEY PROTEINS: ROLE OF GLUTATHIONE.
    Clin Invest Mod. 1991 Aug; 14(4): 296-309.
    Bounous G, Gold P.
  26. WHEY PROTEINS IN CANCER PREVENTION.
    Cancer Lett. 1991 May 1; 57(2): 91-4.
    Bounous G, Gold P.
  27. DIETARY MILK PROTEINS INHIBIT THE DEVELOPMENT OF DIMETHYLHYDRAZINE-INDUCED MALIGNANCY.
    Tumour Biol. 1990; 11(3): 129-36.
    Papenburg R, Bounous G, Fleiszer D, Gold P.
  28. THE INFLUENCE OF DIETARY WHEY PROTEIN ON TISSUE GLUTATHIONE AND THE DISEASES OF AGING.
    Clin Invest Med. 1989 Dec; 12(6): 343-9.
    Bounous G, Gervais F, Amer V, Batist G, Gold P.
  29. IMMUNOENHANCING PROPERTY OF DIETARY WHEY PROTEIN IN MICE: ROLE OF GLUTATHIONE.
    Clin Invest Med. 1989 Jun; 12(3): 154-61.
    Bounous G, Batist G, Gold P.
  30. CHANGES IN BILIARY SECRETORY IMMUNOGLOBULINS A IN MICE FED WHEY PROTEINS.
    Minerva Dietol Gastroenterol 1989 35(4): 241-5.
    Costantino AM, Balzola F, Bounous G.
  31. THE IMMUNOENHANCING PROPERTY OF DIETARY WHEY PROTEIN CONCENTRATE.
    Clin Invest Med. 1988 Aug; 11(4): 271-8.
    Bounous G, Kongshavn PA, Gold P.
  32. DIETARY WHEY PROTEIN INHIBITS THE DEVELOPMENT OF DIMETHYLHYDRAZINE INDUCED MALIGNANCY.
    Clin Invest Med. 1988 Jun; 11(3): 213-7.
    Bounous G, Papenburg R, Kongshavn PA, Gold P, Fleiszer D.
  33. MECHANISM OF ALTERED B-CELL RESPONSE INDUCED BY CHANGES IN DIETARY PROTEIN TYPE IN MICE.
    J Nutr. 1985 Nov; 115(11): 1409-17.
    Bounous G, Shenouda N, Kongshavn PA, Osmond DG.
  34. DIFFERENTIAL EFFECT OF DIETARY PROTEIN TYPE ON THE B-CELL AND T-CELL IMMUNE RESPONSES IN MICE.
    J Nutr. 1985 Nov; 115(11): 1403-8.
    Bounous G, Kongshavn PA.
  35. INFLUENCE OF DIETARY PROTEIN TYPE ON THE IMMUNE SYSTEM OF MICE.
    J Nutr. 1983 Jul; 113(7): 1415-21.
    Bounous G, Letourneau L, Kongshavn PA.
  36. INFLUENCE OF DIETARY PROTEINS ON THE IMMUNE SYSTEM OF MICE.
    J. Nutr. 1982 Sep; 112(9): 1747-55.
    Bounous G, Kongshavn PA.
  37. INFLUENCE OF DIETARY LACTALBUMIN HYDROLYSATE ON THE IMMUNE SYSTEM OF MICE AND RESISTANCE TO SALMONELLOSIS.
    J Infect Dis. 1981 Sept; 144(3): 281.
    Bounous G, Stevenson MM, Kongshavn PA.